Evidence map›Paper›PMID 34714434›Full record

ArticleActa neurochirurgica2022

Proposal of a new grading system for meningioma resection: the Copenhagen Protocol.

Jeppe Haslund-Vinding, Jane Skjoth-Rasmussen, Lars Poulsgaard, Kaare Fugleholm, Christian Mirian, Andrea Daniela Maier, Thomas Santarius, Frantz Rom Poulsen, Torstein Meling, Jiri Junior Bartek and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Postoperative [European journal of nuclear medicine and molecular imaging · 2023
    Article
  6. Radiotherapy and radiosurgery for meningiomas.Neuro-oncology advances · 2023
    Article
  7. Meningiomas with CNS invasion.Frontiers in neuroscience · 2023
    Review
  8. Article
  9. Review
  10. The Role of [Cancers · 2022
    Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Jeppe Haslund-VindingDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. jeppe.lohfert.haslund-vinding.01@regionh.dk.ORCID http://orcid.org/0000-0003-2941-3573
Jane Skjoth-RasmussenDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Lars PoulsgaardDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kaare FugleholmDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Christian MirianDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Andrea Daniela MaierDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Thomas SantariusDepartment of Neurosurgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Frantz Rom PoulsenDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Torstein MelingDepartment of Neurosurgery, Geneva University Hospital, Geneva, Switzerland.
Jiri Junior BartekDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Petter FöranderDepartment of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.
Vibeke Andrée LarsenDepartment of Radiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Bjarne Winther KristensenDepartment of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.
David ScheieDepartment of Clinical Neuroscience, Section for Neurosurgery, Karolinska Institutet, Stockholm, Sweden.
Ian LawDepartment of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark.
Morten ZiebellDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Tiit MathiesenDepartment of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Copenhagen University Hospital · DKUniversity of Copenhagen · DKKarolinska University Hospital · SECambridge University Hospitals NHS Foundation Trust · GBKarolinska Institutet · SEUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe extent of meningioma resection is the most fundamental risk factor for recurrence, and exact knowledge of extent of resection is necessary for prognostication and for planning of adjuvant treatment. Currently used classifications are the EANO-grading and the Simpson grading. The former comprises radiological imaging with contrast-enhanced MRI and differentiation between "gross total removal" and "subtotal removal," while the latter comprises a five-tiered differentiation of the surgeon's impression of the extent of resection. The extent of resection of tumors is usually defined via analyses of resection margins but has until now not been implemented for meningiomas. PET/MRI imaging with

objectiveTo develop an objective grading system based on microscopic analyses of resection margins and sensitive radiological analyses to improve management of follow-up, adjuvant therapy, and prognostication of meningiomas. Based on the rationale of resection-margin analyses as gold standard and superior imaging performance of

resultsCopenhagen Grading was described for six pilot patients with examples of positive and negative findings on histopathology and DOTATOC PET scanning. The grading could be traceably implemented and parameters of grading appeared complementary. Copenhagen Grading is prospectively implemented as a clinical standard at Rigshospitalet, Copenhagen.

conclusionCopenhagen Grading provided a comprehensive, logical, and reproducible definition of the extent of resection. It offers promise to be the most sensitive and specific imaging modality available for meningiomas. Clinical and cost-efficacy remain to be established during prospective implementation.

Indexed as

Meningeal NeoplasmsMeningiomaHumansNeoplasm GradingNeoplasm Recurrence, LocalPositron-Emission TomographyProspective StudiesRetrospective StudiesMeningiomaNeurooncologyNeuropathologyNeuroradiologyNeurosurgery

Identifiers

PMID34714434
OpenAlexW3210230758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.